Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT00193466 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkins Lymphoma

Interventions

DRUG: Rituximab
DRUG: Fludarabine
DRUG: CAMPTH-1H

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]